Plandai Biotechnology (Plandai Biotechnology) Net Income From Continuing Operations : $-19.80 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Plandai Biotechnology's net income from continuing operations for the six months ended in Jun. 2023 was $-19.80 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.80 Mil.

Plandai Biotechnology Net Income From Continuing Operations Historical Data

The historical data trend for Plandai Biotechnology's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Net Income From Continuing Operations Chart

Plandai Biotechnology Annual Data

Trend

Mar09

Mar10

Mar11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun22

Jun23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-16.05

-10.07

-4.74

6.82

-19.80

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
Net Income From Continuing Operations	Get a 7-Day Free Trial											-16.05	-10.07	-4.74	6.82	-19.80

Plandai Biotechnology Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 was $-19.80 Mil.

Plandai Biotechnology (Plandai Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

4811 49th Street, San Diego, CA, USA, 92115

Website

http://www.plandaibiotech.com

Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.

Executives

Callum Baylis-duffield	director	FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula	other: Former Director	175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson	director	P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield	director, officer: President, Secretary and CFO	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield	director	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki	director	21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866